用户名  找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

SCIE期刊CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS 2024/2025影响因子:2.496 (CANCER BIOTHER RADIO) (1084-9785). (RADIOLOGY, NU

[复制链接]
楼主: peak-flow-meter
发表于 2025-3-26 23:59:06 | 显示全部楼层
Submitted on: 07 May 2006. Revised on: 02 September 2006. Accepted on: 24 October 2006. ___________________CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
发表于 2025-3-27 04:10:34 | 显示全部楼层
Submitted on: 18 September 2006. Revised on: 23 October 2006. Accepted on: 08 December 2006. ___________________CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
发表于 2025-3-27 06:59:49 | 显示全部楼层
Submitted on: 08 August 2000. Revised on: 15 October 2000. Accepted on: 30 November 2000. ___________________CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
发表于 2025-3-27 10:29:35 | 显示全部楼层
发表于 2025-3-27 14:52:46 | 显示全部楼层
Submitted on: 10 October 2008. Revised on: 28 January 2009. Accepted on: 23 February 2009. ___________________CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
发表于 2025-3-27 20:14:11 | 显示全部楼层
Submitted on: 06 June 2001. Revised on: 20 August 2001. Accepted on: 28 September 2001. ___________________CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-5 00:41
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表